TrialBritish journal of clinical pharmacology2017

Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects.

Juliet McColm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.